Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
TC Energy
TRP
|
+$1.49B |
| 2 |
Constellation Brands
STZ
|
+$1.48B |
| 3 |
Broadcom
AVGO
|
+$1.35B |
| 4 |
Alcon
ALC
|
+$1.28B |
| 5 |
UnitedHealth
UNH
|
+$1.03B |
Top Sells
| 1 |
AbbVie
ABBV
|
+$2.65B |
| 2 |
Verizon
VZ
|
+$1.88B |
| 3 |
Booking.com
BKNG
|
+$1.54B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.35B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.35B |
Sector Composition
| 1 | Healthcare | 19.37% |
| 2 | Technology | 16.98% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Communication Services | 11.95% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Cisco
CSCO
$263B
| $209M | 0.07% |
3,817,453
-7,779,552
| -67% | -$426M |
|
202
Texas Roadhouse
TXRH
$11.1B
| $204M | 0.06% |
3,808,305
-481,862
| -11% | -$25.9M |
|
203
Xcel Energy
XEL
$43.4B
| $200M | 0.06% |
3,368,235
+3,092
| +0.1% | +$184K |
|
204
Intuit
INTU
$180B
| $200M | 0.06% |
765,749
+523
| +0.1% | +$137K |
|
205
Paycom
PAYC
$12.5B
| $199M | 0.06% |
875,980
-747,100
| -46% | -$169M |
|
206
Ecolab
ECL
$77.3B
| $196M | 0.06% |
991,941
+630
| +0.1% | +$124K |
|
207
CONMED
CNMD
$1.64B
| $194M | 0.06% |
2,270,162
+369,000
| +19% | +$31.6M |
|
208
Cannae Holdings
CNNE
$1.11B
| $192M | 0.06% |
6,620,000
| – | – |
|
209
Boston Scientific
BSX
$152B
| $192M | 0.06% |
4,458,961
-1,917,874
| -30% | -$82.4M |
|
210
Telus
TU
$24.3B
| $191M | 0.06% |
10,330,320
+8,932
| +0.1% | +$165K |
|
211
East-West Bancorp
EWBC
$15.1B
| $190M | 0.06% |
4,057,046
+3,058
| +0.1% | +$143K |
|
212
Automatic Data Processing
ADP
$119B
| $187M | 0.06% |
1,131,887
+253,887
| +29% | +$42M |
|
|
ALLK
213
DELISTED
Allakos
ALLK
| $183M | 0.06% |
4,218,788
+26,191
| +0.6% | +$1.13M |
|
214
Kroger
KR
$45.2B
| $183M | 0.06% |
8,412,860
-353,024
| -4% | -$7.66M |
|
215
West Pharmaceutical
WST
$18.2B
| $180M | 0.06% |
1,436,834
+967
| +0.1% | +$121K |
|
|
MGP
216
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $179M | 0.06% |
5,830,700
-67,500
| -1% | -$2.07M |
|
217
Madrigal Pharmaceuticals
MDGL
$9.63B
| $176M | 0.06% |
1,683,262
+18,810
| +1% | +$1.97M |
|
218
Novartis
NVS
$240B
| $174M | 0.06% |
1,902,109
+172,214
| +10% | +$15.7M |
|
219
Dine Brands
DIN
$368M
| $172M | 0.05% |
1,798,937
-125,320
| -7% | -$12M |
|
220
Comcast
CMCSA
$122B
| $171M | 0.05% |
4,048,953
+2,513
| +0.1% | +$106K |
|
|
IPHI
221
DELISTED
INPHI CORPORATION
IPHI
| $171M | 0.05% |
3,405,310
-31,038
| -0.9% | -$1.56M |
|
222
LivaNova
LIVN
$3.07B
| $171M | 0.05% |
2,370,699
+1,450,799
| +158% | +$104M |
|
|
TMX
223
DELISTED
Terminix Global Holdings, Inc.
TMX
| $167M | 0.05% |
3,200,250
-282,000
| -8% | -$14.7M |
|
224
Progressive
PGR
$146B
| $160M | 0.05% |
2,001,896
-117,272
| -6% | -$9.37M |
|
225
Webster Financial
WBS
$10.2B
| $159M | 0.05% |
3,331,749
-774,425
| -19% | -$37M |
|